Table 2 Effect of the regional cooling on the prescription of the PN therapeutic drug and PTX doses reduction due to PN
From: The effectiveness of regional cooling for paclitaxel-induced peripheral neuropathy
Cycle | Control group (n = 142) | Regional cooling group (n = 40) | p-value |
|---|---|---|---|
Prescription of the PN therapeutic drug※ | 52 (36.6 %) | 11 (27.5 %) | P = 0.378 |
PTX doses reduction due to PN | 5 (3.5 %) | 2 (5.0 %) | P = 0.645 |